Get the Stockscreener App
17.61
1.24%
0.215
Mediwound Ltd stock is traded at $17.61, with a volume of 79,455.
It is up +1.24% in the last 24 hours and down -14.08% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$17.39
Open:
$17.35
24h Volume:
79,455
Relative Volume:
1.22
Market Cap:
$190.27M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.76
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-2.73%
1M Performance:
-14.08%
6M Performance:
-0.42%
1Y Performance:
-6.21%
1-Day Range:
$17.35
$18.00
1-Week Range:
$17.05
$18.40
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.61 | 191.41M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Enzymatic Therapeutics Leader MediWound to Present Latest Developments at Global Investment Conference - Stock Titan
MediWound Ltd. Recovery Hinges on Volume Breakout2025 Fundamental Recap & Risk Managed Investment Strategies - beatles.ru
How to monitor MediWound Ltd. with trend dashboards2025 Fundamental Recap & Reliable Price Breakout Alerts - Newser
Momentum divergence signals in MediWound Ltd. chart2025 Growth vs Value & Safe Entry Momentum Stock Tips - Newser
Signal strength of MediWound Ltd. stock in tech scanners2025 Historical Comparison & Consistent Growth Stock Picks - Newser
Can MediWound Ltd. hit a new high this monthWeekly Earnings Recap & Real-Time Market Sentiment Alerts - Newser
Does MediWound Ltd. show high probability of reboundShort Setup & Capital Efficient Trade Techniques - Newser
What’s the recovery path for long term holders of MediWound Ltd. - Newser
Is MediWound Ltd. stock a good hedge against inflation2025 Price Targets & Long Hold Capital Preservation Tips - Newser
Key resistance and support levels for MediWound Ltd.Gap Down & Long-Term Safe Investment Plans - Newser
MediWound Executives Purchase Shares, Signaling Confidence - TipRanks
Is MediWound Ltd. forming a bottoming baseWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Using Ichimoku Cloud for MediWound Ltd. technicals2025 Breakouts & Breakdowns & Consistent Profit Alerts - Newser
Is MediWound Ltd. stock ready for a breakoutQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - Newser
Price action breakdown for MediWound Ltd.July 2025 Price Swings & Expert Verified Movement Alerts - Newser
Combining machine learning predictions for MediWound Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser
Volatility clustering patterns for MediWound Ltd.Price Action & Reliable Price Breakout Signals - Newser
MediWound's (MDWD) Q2 2025 Earnings and Strategic Progress Amid Rising Losses: A Balancing Act of Risk and Reward - AInvest
Is MediWound Ltd. stock risky to hold nowInsider Buying & Intraday High Probability Alerts - thegnnews.com
Analysts Have Made A Financial Statement On MediWound Ltd.'s (NASDAQ:MDWD) Second-Quarter Report - ca.finance.yahoo.com
Real time social sentiment graph for MediWound Ltd.2025 Top Gainers & Community Verified Trade Signals - Newser
MediWound Ltd Q2 2025 Earnings Call Highlights: Revenue Growth Amid Rising Costs - AInvest
What’s next for MediWound Ltd. stock priceWeekly Loss Report & Long-Term Capital Growth Strategies - Newser
Top chart patterns to watch in MediWound Ltd.New Guidance & AI Powered Market Trend Analysis - Newser
Has MediWound Ltd. formed a bullish divergence2025 Technical Patterns & Weekly Return Optimization Plans - Newser
MediWound Ltd. Price Holds Above Key Fib LevelJuly 2025 Sentiment & AI Driven Price Forecasts - kangso.co.kr
How to track smart money flows in MediWound Ltd.Portfolio Value Report & Risk Managed Trade Strategies - Newser
What chart patterns are forming on MediWound Ltd.2025 Earnings Impact & Safe Capital Growth Trade Ideas - thegnnews.com
Can MediWound Ltd. stock double in the next yearQuarterly Investment Review & Risk Managed Investment Signals - sundaytimes.kr
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
MediWound Ltd. stock outlook for YEARDay Trade & Free Risk Controlled Daily Trade Plans - Newser
How to integrate MediWound Ltd. into portfolio analysis toolsWeekly Gains Report & Expert Approved Trade Ideas - Newser
Can machine learning forecast MediWound Ltd. recoveryBuy Signal & Weekly Stock Performance Updates - Newser
Published on: 2025-08-16 11:03:28 - sundaytimes.kr
Can MediWound Ltd. navigate macro headwindsFed Meeting & Risk Controlled Daily Trade Plans - 선데이타임즈
Reversal Traders Monitor MediWound Ltd. for Entry2025 Earnings Impact & Daily Chart Pattern Signal Reports - sundaytimes.kr
MediWound Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
MediWound: Q2 Earnings Snapshot - Norwalk Hour
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
MediWound Revenue Jumps 43% in Q2 - AOL.com
MediWound Reports Strong Q2 Growth and Strategic Advances - TipRanks
MediWound Q2 2025 Earnings Call Transcript - MarketBeat
MediWound Ltd. Breakout Confirmed by Volume MetricsJuly 2025 Review & Growth Focused Stock Pick Reports - classian.co.kr
MediWound Revenue Jumps 43% in Q2 - The Motley Fool
Mediwound earnings missed by $0.66, revenue topped estimates - Investing.com India
Mediwound earnings missed by $0.66, revenue topped estimates By Investing.com - Investing.com South Africa
MediWound (MDWD) Q2 2025 Earnings Call Transcript - AOL.com
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):